Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia
Cancer, 05/25/2012
Borthakur G et al. – The current results indicated that time–to–event analyses of patients with normal–karyotype acute myelogenous leukemia and fms–like tyrosine kinase receptor 3 internal tandem duplication (FLT3–ITD) mutation should take into account the number of mutations and the mutant burden, among other factors.
